|Articles|January 29, 2009
First Discussion Opportunity for EC Pharmaceutical Package
Advertisement
A New Vision for the Pharmaceutical Sector-First Discussion Opportunity for European Commission Pharmaceutical Package
Brussels- The first in-depth opportunity to understand, debate and influence new European Commission (EC) legislative changes and their implications-the Proposals for new Pharmaceutical Legislation EU update meeting-is being hosted by The Organisation for Professionals in Regulatory Affairs (TOPRA) on 25-26 February 2009.
Over the two days of this meeting nearly 20 speakers from the European Commission, pan-European national agencies, national authorities and industry will discuss the European Pharmaceutical Package announced by the European Commission on 10th December 2008 and give their view on the new legislation proposals.
Issues discussed at the conference will include the development, purpose and expected outcomes of the pharmaceutical package, counterfeit medicines, information to patients and pharmacovigilance. Please find
attached the draft programme which gives further detail.
This conference has relevance for all of industry, health agencies and other stakeholders. It should be attended by anyone that the 'Pharma Package' will affect.
The organisers would like to take this opportunity to invite you to conference and take advantage of a number of free press passes that are available.
Over the two days of this meeting nearly 20 speakers from the European Commission, pan-European national agencies, national authorities and industry will discuss the European Pharmaceutical Package announced by the European Commission on 10th December 2008 and give their view on the new legislation proposals.
Issues discussed at the conference will include the development, purpose and expected outcomes of the pharmaceutical package, counterfeit medicines, information to patients and pharmacovigilance. Please find
attached the draft programme which gives further detail.
This conference has relevance for all of industry, health agencies and other stakeholders. It should be attended by anyone that the 'Pharma Package' will affect.
The organisers would like to take this opportunity to invite you to conference and take advantage of a number of free press passes that are available.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement




.png)



.png)



.png)
.png)
